课题基金 / 基金详情

项目摘要

项目成果

Vickery E Trinkaus-Randall的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Amyloid fibrils are composed of abnormally refolded proteins. AFM has demonstrated its capability to elucidate the in vitro fibril formation process. The fibril formation of amyloid protein such as Amyloid-¿ and recombinant IgG lightchain has been reported. The model proposed by Ionescu-Zanetti et al shows that the amyloid proteins form ¿-sheet structures to become a single filament in the diameter around 2.4 nm. Then two or more filaments can intertwine to form larger size protofilbrils or fibrils directly. This AFM project is related to our other amyloid mass spectrometry projects, and focuses on IgG light-chains purified from patient organs and resuspended in solution, as well as the fibrils taken directly from human organs. Purified urinary IgG light chain protein (01-029) was incubated at 0.03 mM in the presence of buffer and 100 mM NaCl solution at 37 deg C with moderate stirring. Standard buffers included 20 mM HCl, 20 mM TRIS, and 50 mM acetate. Aliquots were taken at different times for AFM analysis under tapping mode. Our preliminary data showed that the rate of fibril formation is very dependent on the incubation conditions, such as pH, stirring. Fibrils were observed at pH 2 with stirring, but not at pH 5.5 and 7.5. The conformation of the amyloid fibrils purified from patient organs were also measured, and the mass spectral characteristics of each of these and their proteolytic digests were also determined. Different experimental conditions will be tested for IgG light-chain fibril formation. The effects of glycosaminoglycan including heparin, heparin sulfate during the fibril formation are currently being explored.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Mechanisms of corneal wound repair
  • 批准号:
    10674734
  • 项目类别:
  • 资助金额:
    $41.25万
  • 财政年份:
    2021
  • 负责人:
    Vickery E Trinkaus-Randall
  • 依托单位:
Molecular Mechanisms of corneal wound repair
  • 批准号:
    10296958
  • 项目类别:
  • 资助金额:
    $41.25万
  • 财政年份:
    2021
  • 负责人:
    Vickery E Trinkaus-Randall
  • 依托单位:
Molecular Mechanisms of corneal wound repair
  • 批准号:
    10470861
  • 项目类别:
  • 资助金额:
    $40.01万
  • 财政年份:
    2021
  • 负责人:
    Vickery E Trinkaus-Randall
  • 依托单位:
Multicellular regulation of corneal wound healing
  • 批准号:
    8975202
  • 项目类别:
  • 资助金额:
    $20.46万
  • 财政年份:
    2014
  • 负责人:
    Vickery E Trinkaus-Randall
  • 依托单位:
海外基金